IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR ENOXAPARIN BIOSIMILARS (INHIXA and AROVI)

Yuet Wan, Medicines Information Pharmacist, London and South East Regional Medicines InformationSource London and South East Regional Medicines InformationPublished

This UKMi Product Safety assessment on Inhixa and Arovi (enoxaparin biosimilars) describes the in-use medication safety considerations resultant from the products’ presentation or other pre-defined characteristics. Potential next steps and mitigation actions are suggested. It has been produced using the validated UKMi product assessment tool.

Attachments